EPSTEIN ALAN L has a total of 15 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VIVENTIA BIOTECH INC, FUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS and KOLLTAN PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Epstein Alan L | 15 |
#2 | Hu Peisheng | 5 |
#3 | Khawli Leslie A | 4 |
#4 | Li Jiali | 3 |
#5 | Lechner Melissa G | 2 |
#6 | Hu Peishing | 1 |
#7 | Ohlfest John | 1 |
Publication | Filing date | Title |
---|---|---|
CN107847601A | The CAR cellular immunotherapies that LYM 1 and LYM 2 is targetted | |
US2015191525A1 | OX40L fusion protein for the immunotherapy of tumors of veterinary animals | |
WO2005072479A2 | Polymer-bound antibody concer therapeutic agent |